ChenGuang Biotech Group: Strong Financials Despite Weakness?
ChenGuang Biotech Group's share price has dropped 7.5% in the past three months. However, their ROE of 14% shows a ...
- Latest
- Trending
ChenGuang Biotech Group's share price has dropped 7.5% in the past three months. However, their ROE of 14% shows a ...
Trump is selling special edition Bibles to raise funds, possibly due to poor business results with TruthSocial. With lock-up period ...
Explore the financial intricacies of Tennessee Valley Authority Debenture Series D as it navigates market fluctuations. Unlock insights in the ...
A group of 36 lawmakers penned a letter urging the US administration to address the barriers and glitches in the ...
America needs a "dead hand" system more than ever. Algorithms play a critical role in learning, but their designers determine ...
Moleculin Biotech's stock has been given a "sell" rating by a firm, with a 1-year low of $4.34 and a ...
JPMorgan and Morgan Stanley are offering a tool to help customers plan for retirement by connecting them with financial advisers ...
Unleash the power of cryptocurrency trading bots! Discover how automation and algorithms can give you an edge in the volatile ...
The growing AI in drug discovery market is driven by the increasing amount of data in drug development. However, restraints ...
The stock has dropped 29% in the last year, hitting a low of $11.25 on Oct. 27. A study shows ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.